Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Cash from Financing Activities (2024 - 2025)

Profound Medical (PROF) has 2 years of Cash from Financing Activities data on record, last reported at $41.4 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million; the TTM value through Dec 2025 reached $41.1 million, down 24.79%, while the annual FY2025 figure was $41.1 million, 24.79% down from the prior year.
  • Cash from Financing Activities reached $41.4 million in Q4 2025 per PROF's latest filing, up from -$290000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $41.4 million in Q4 2025 and bottomed at -$603000.0 in Q2 2024.